Loading company…
Tianneng Jingxiu develops maize breeding technology based on nuclear male sterility.
Tianneng Jingxiu develops nuclear male sterility technology, propagation services and breeding conversion services for hybrid maize seed producers. Founded in 2023 and based in Chengdu, China, it raised Series A funding in July 2026 from Geuniom Group, Tianfu Science and Technology Venture Capital, Molbreeding Biotechnology Co., Ltd., Dinghao Development Equity Investment Fund Management and Starlight Capital. The company plans to expand seed production areas and pursue safety certificates.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in